Literature DB >> 18242511

Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells.

Jianqiang Wu1, Jon P Williams, Tilat A Rizvi, Jennifer J Kordich, David Witte, Dies Meijer, Anat O Stemmer-Rachamimov, Jose A Cancelas, Nancy Ratner.   

Abstract

Neurofibromatosis type 1 (Nf1) mutation predisposes to benign peripheral nerve (glial) tumors called neurofibromas. The point(s) in development when Nf1 loss promotes neurofibroma formation are unknown. We show that inactivation of Nf1 in the glial lineage in vitro at embryonic day 12.5 + 1, but not earlier (neural crest) or later (mature Schwann cell), results in colony-forming cells capable of multilineage differentiation. In vivo, inactivation of Nf1 using a DhhCre driver beginning at E12.5 elicits plexiform neurofibromas, dermal neurofibromas, and pigmentation. Tumor Schwann cells uniquely show biallelic Nf1 inactivation. Peripheral nerve and tumors contain transiently proliferating Schwann cells that lose axonal contact, providing insight into early neurofibroma formation. We suggest that timing of Nf1 mutation is critical for neurofibroma formation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18242511      PMCID: PMC2846699          DOI: 10.1016/j.ccr.2007.12.027

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  49 in total

1.  Mouse models of tumor development in neurofibromatosis type 1.

Authors:  K Cichowski; T S Shih; E Schmitt; S Santiago; K Reilly; M E McLaughlin; R T Bronson; T Jacks
Journal:  Science       Date:  1999-12-10       Impact factor: 47.728

2.  Mouse tumor model for neurofibromatosis type 1.

Authors:  K S Vogel; L J Klesse; S Velasco-Miguel; K Meyers; E J Rushing; L F Parada
Journal:  Science       Date:  1999-12-10       Impact factor: 47.728

3.  Schwann cell preparation from single mouse embryos: analyses of neurofibromin function in Schwann cells.

Authors:  Nancy Ratner; Jon P Williams; Jennifer J Kordich; Haesun A Kim
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

4.  Single cell Ras-GTP analysis reveals altered Ras activity in a subpopulation of neurofibroma Schwann cells but not fibroblasts.

Authors:  L S Sherman; R Atit; T Rosenbaum; A D Cox; N Ratner
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

Review 5.  Lineage diversification of the neural crest: in vitro investigations.

Authors:  D L Stemple; D J Anderson
Journal:  Dev Biol       Date:  1993-09       Impact factor: 3.582

6.  Suppression of the p75 neurotrophin receptor in uninjured sensory neurons reduces neuropathic pain after nerve injury.

Authors:  Koichi Obata; Hirokazu Katsura; Jun Sakurai; Kimiko Kobayashi; Hiroki Yamanaka; Yi Dai; Tetsuo Fukuoka; Koichi Noguchi
Journal:  J Neurosci       Date:  2006-11-15       Impact factor: 6.167

7.  A negative feedback signaling network underlies oncogene-induced senescence.

Authors:  Stéphanie Courtois-Cox; Sybil M Genther Williams; Elizabeth E Reczek; Bryan W Johnson; Lauren T McGillicuddy; Cory M Johannessen; Pablo E Hollstein; Mia MacCollin; Karen Cichowski
Journal:  Cancer Cell       Date:  2006-12       Impact factor: 31.743

8.  Conditional N-rasG12V expression promotes manifestations of neurofibromatosis in a mouse model.

Authors:  H Saito; T Yoshida; H Yamazaki; N Suzuki
Journal:  Oncogene       Date:  2007-01-22       Impact factor: 9.867

9.  Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1.

Authors:  Ophélia Maertens; Sofie De Schepper; Jo Vandesompele; Hilde Brems; Ine Heyns; Sandra Janssens; Frank Speleman; Eric Legius; Ludwine Messiaen
Journal:  Am J Hum Genet       Date:  2007-06-20       Impact factor: 11.025

10.  Neural crest-derived cells with stem cell features can be traced back to multiple lineages in the adult skin.

Authors:  Christine E Wong; Christian Paratore; María T Dours-Zimmermann; Ariane Rochat; Thomas Pietri; Ueli Suter; Dieter R Zimmermann; Sylvie Dufour; Jean Paul Thiery; Dies Meijer; Friedrich Beermann; Yann Barrandon; Lukas Sommer
Journal:  J Cell Biol       Date:  2006-12-11       Impact factor: 10.539

View more
  114 in total

Review 1.  Cancer stem cells: a stride towards cancer cure?

Authors:  Amitava Sengupta; Jose A Cancelas
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

Review 2.  Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.

Authors:  Steven L Carroll
Journal:  Acta Neuropathol       Date:  2011-12-11       Impact factor: 17.088

3.  Back to the future: proceedings from the 2010 NF Conference.

Authors:  Susan M Huson; Maria T Acosta; Allan J Belzberg; Andre Bernards; Jonathan Chernoff; Karen Cichowski; D Gareth Evans; Rosalie E Ferner; Marco Giovannini; Bruce R Korf; Robert Listernick; Kathryn N North; Roger J Packer; Luis F Parada; Juha Peltonen; Vijaya Ramesh; Karlyne M Reilly; John W Risner; Elizabeth K Schorry; Meena Upadhyaya; David H Viskochil; Yuan Zhu; Kim Hunter-Schaedle; Filippo G Giancotti
Journal:  Am J Med Genet A       Date:  2010-12-22       Impact factor: 2.802

Review 4.  Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression.

Authors:  Karl Staser; Feng-Chun Yang; D Wade Clapp
Journal:  Annu Rev Pathol       Date:  2011-11-07       Impact factor: 23.472

Review 5.  Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems.

Authors:  Fausto J Rodriguez; Andrew L Folpe; Caterina Giannini; Arie Perry
Journal:  Acta Neuropathol       Date:  2012-02-12       Impact factor: 17.088

Review 6.  Glial versus melanocyte cell fate choice: Schwann cell precursors as a cellular origin of melanocytes.

Authors:  Igor Adameyko; Francois Lallemend
Journal:  Cell Mol Life Sci       Date:  2010-05-09       Impact factor: 9.261

7.  Preclinical Evidence for the Use of Sunitinib Malate in the Treatment of Plexiform Neurofibromas.

Authors:  Michael J Ferguson; Steven D Rhodes; Li Jiang; Xiaohong Li; Jin Yuan; Xianlin Yang; Shaobo Zhang; Saeed T Vakili; Paul Territo; Gary Hutchins; Feng-Chun Yang; David A Ingram; D Wade Clapp; Shi Chen
Journal:  Pediatr Blood Cancer       Date:  2015-09-16       Impact factor: 3.167

8.  Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumors.

Authors:  Vincent Chau; S Kyun Lim; Wei Mo; Chiachi Liu; Amish J Patel; Renée M McKay; Shuguang Wei; Bruce A Posner; Jef K De Brabander; Noelle S Williams; Luis F Parada; Lu Q Le
Journal:  Cancer Res       Date:  2013-11-27       Impact factor: 12.701

9.  Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition.

Authors:  Carlos E Prada; Edwin Jousma; Tilat A Rizvi; Jianqiang Wu; R Scott Dunn; Debra A Mayes; Jose A Cancelas; Eva Dombi; Mi-Ok Kim; Brian L West; Gideon Bollag; Nancy Ratner
Journal:  Acta Neuropathol       Date:  2012-10-26       Impact factor: 17.088

10.  MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.

Authors:  Walter J Jessen; Shyra J Miller; Edwin Jousma; Jianqiang Wu; Tilat A Rizvi; Meghan E Brundage; David Eaves; Brigitte Widemann; Mi-Ok Kim; Eva Dombi; Jessica Sabo; Atira Hardiman Dudley; Michiko Niwa-Kawakita; Grier P Page; Marco Giovannini; Bruce J Aronow; Timothy P Cripe; Nancy Ratner
Journal:  J Clin Invest       Date:  2012-12-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.